Suppr超能文献

高敏心肌肌钙蛋白 T 和肌酸激酶同工酶 MB 在急性心肌梗死合并慢性肾脏病患者中的预后标志物作用。

The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease.

机构信息

Department of Cardiology, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.

Shaoguan College of Medicine, Shaoguan, China.

出版信息

Ren Fail. 2023 Dec;45(1):2220420. doi: 10.1080/0886022X.2023.2220420.

Abstract

High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking. We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve. The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789-0.894) and 0.821 (95% CI: 0.760-0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03-9.86;  = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54-14.68;  = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02-8.24;  = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66-16.86,  = 0.005). Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD.

摘要

高敏肌钙蛋白 T(hs-cTnT)和肌酸激酶同工酶(CK-MB)是诊断和预测急性心肌梗死(AMI)的最常用生物标志物。慢性肾脏病(CKD)患者常伴有 hs-cTnT 水平升高,但目前缺乏比较 hs-cTnT 和 CK-MB 在 AMI 合并 CKD 患者中预后价值的研究。我们对 2015 年 1 月至 2020 年 10 月期间诊断为 AMI 的患者进行了回顾性研究。根据肾功能将患者分为正常或 CKD。收集住院期间 hs-cTnT 和 CK-MB 的峰值水平,并使用接收者操作特征(ROC)曲线评估其诊断价值。采用多变量 logistic 回归分析其对住院死亡率的影响。使用受限立方样条(RCS)曲线分析 hs-cTnT/CK-MB 比值与住院死亡的关系。该研究纳入了 5022 例 AMI 患者,其中 797 例(15.9%)患有 CKD。与肾功能正常组[0.695(95%CI:0.604-0.790)和 0.708(95%CI:0.624-0.793)]相比,CKD 组 hs-cTnT 和 CK-MB 的 AUC 更高[0.842(95%CI:0.789-0.894)和 0.821(95%CI:0.760-0.882)]。在对所有危险因素进行完全调整后,hs-cTnT(OR,2.82;95%CI,1.03-9.86; = 0.038)和 CK-MB(OR,4.91;95%CI,1.54-14.68; = 0.007)超过截断值是 CKD 患者住院死亡率的独立预测因素。然而,在肾功能正常的患者中,只有 CK-MB 超过截断值(OR,2.45;95%CI,1.02-8.24; = 0.046)与住院死亡率相关,而 hs-cTnT 则无。hs-cTnT/CK-MB 比值与住院死亡率呈倒 V 形关系,拐点为 19.61。第二四分位数(9.63-19.6)内的比值是 CKD 患者住院死亡率的独立预测因素(OR 5.3,95%CI 1.66-16.86, = 0.005)。hs-cTnT 可独立预测 CKD 合并 AMI 患者的住院死亡率,而在肾功能正常的患者中未观察到其预测价值。CK-MB 是住院死亡率的独立预测因素,而与肾功能无关。此外,hs-cTnT/CK-MB 比值可能有助于 CKD 合并 AMI 患者的风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cb/10246482/592bfb7b25d0/IRNF_A_2220420_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验